Distribution · Yemen

Choosing a distribution partner in Yemen: what to look for

Picking the right distributor is one of the highest-leverage decisions a manufacturer makes when entering a new market. The right partner becomes your registration team, your logistics arm, your warehouse and your sales force — and, crucially, a guardian of your product's quality and reputation. Here is what to assess, and why it matters.

Why quality is the first question

The stakes are set by a sobering figure. The World Health Organization estimates that around 1 in 10 medical products in low- and middle-income countries is substandard or falsified — a failure rate of roughly 10.5%, based on more than 100 studies across 88 countries and 48,000 samples.¹

The consequences are severe. WHO reports that countries spend an estimated US$30.5 billion a year on substandard and falsified medical products;² that modelling suggests 72,000–169,000 children may die each year from pneumonia linked to substandard or falsified antibiotics; and that a further 116,000 malaria deaths a year in sub-Saharan Africa may be attributable to substandard or falsified antimalarials.¹

For a manufacturer, a distributor with weak controls doesn't just risk lost sales — it risks your brand being associated with product failure. Quality assurance is therefore the first thing to evaluate, not the last.

1. Licensing and standing

Confirm the distributor is properly licensed to import and distribute in your product category, and is a recognised legal entity. This is the baseline for everything else, and your first line of defence against the quality risks above.

2. A registration track record

Registration is where many market entries stall. In Yemen, pharmaceuticals and medical devices are registered through the Ministry of Public Health and Population and the Ministry of Industry and Trade; devices follow an EU-style risk classification and usually require an in-country authorised representative. Ask what your prospective partner has registered before, and how they manage dossiers and timelines — it directly affects your speed to market.

3. Cold-chain capability

If any of your products are temperature-sensitive, this is decisive. Most freeze-sensitive vaccines must stay between 2°C and 8°C,⁴ and potency lost to a temperature excursion is cumulative and is not recovered by returning the product to the correct range.⁶ Because such excursions are common in practice — a systematic review found 14–35% of refrigerators or shipments exposed vaccines to freezing⁵ — ask specifically about refrigerated storage, refrigerated transport, temperature monitoring, and how the partner handles a cold-chain exception when one occurs.

4. Technical support and training

For laboratory equipment and instruments, distribution alone is not enough. A strong partner provides installation, training, maintenance and after-sales support, so your product performs — and is seen to perform — in real use.

5. Reach and responsiveness

Demand in Yemen is spread across northern and southern Yemen, not concentrated in one city, and much of it is acute. Can the partner actually serve customers across the country, and how quickly do they respond? Responsiveness before a deal is a fair predictor of service after it.

6. Clear exclusivity terms

If you are granting exclusivity, define it precisely: the territory (the Republic of Yemen), the named products, and the term, all under a signed agreement. Clear terms protect the relationship — and the product — on both sides.

In summary

In a market where roughly one in ten medical products is substandard or falsified, your distributor is your quality firewall as much as your sales channel. Weigh licensing, registration experience, cold chain, technical support, reach and clean exclusivity terms. A partner strong across all six turns a difficult market into a dependable — and defensible — channel.